BioAge Labs, Inc. (BIOA) Cash Flow Statement
BioAge Labs, Inc. (BIOA) generated -$87.6M of operating cash flow over the twelve months to 2026-06-30, spent $488000 on capital expenditure and had free cash flow of -$88.1M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
BIOABioAge Labs, Inc.Follow BIOA — free
—
Price chart with a free account
- Market cap
- 234.1M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
| Line | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|
| Operating cash flow | -81.6 | -87.6 | |
| Capital expenditure | 0.7 | -0.5 | |
| Free cash flow | -82.3 | -88.1 | |
| Stock-based compensation | 11.7 | — |
USD millions · SEC XBRL
BioAge Labs, Inc. — questions
- What is BioAge Labs, Inc.'s operating cash flow?
- -$87.6M over the twelve months to 2026-06-30.
- How much does BioAge Labs, Inc. spend on capital expenditure?
- $488000 over the twelve months to 2026-06-30.
- What is BioAge Labs, Inc.'s free cash flow?
- -$88.1M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from BioAge Labs, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.